GlaxoSmithKline PLC — Director's Dealing 2016

Feb 1, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7059N

GlaxoSmithKline PLC

01 February 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) I give details of changes in the notional interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR'), who acquired Ordinary Shares and American Depositary Shares (ADSs), at a price of 1380.50 pence per Ordinary Share and $40.28 per ADS, following the re-investment of dividends paid to Shareholders on 14 January 2016, on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.

Director/PDMR	Number of Ordinary Shares acquired under the personal contribution element of the plan	Number of Ordinary Shares acquired under the matching element of the plan (GSK contribution)
Sir Andrew Witty	1,793.426	1,793.426
Mr S Dingemans	684.427	684.427
Mr R G Connor	357.433	357.433
Mr N Hirons	77.446	77.446
Mr S A Hussain	306.724	306.724
Mr D S Redfern	383.037	383.037
Ms C Thomas	262.846	262.846
Mr P C Thomson	129.188	129.188
Dr P J T Vallance	917.547	917.547
Ms E Walmsley	541.228	541.228

Director/PDMR	Number of ADSs acquired under the personal contribution element of the plan	Number of ADSs acquired  under the matching element of the plan (GSK contribution)
Dr M M Slaoui	687.416	687.416
Mr D E Troy	290.867	290.867

GlaxoSmithKline plc ('GSK') was advised of these allocations on 28 January 2016.

V A Whyte

Company Secretary

1 February 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSDFLFBQLFBBBL